News – Page 531 – Endpoints News

Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt

4 years ago

Potential deal reached to finalize TRIPS waiver over Covid-19 vaccine IP rights

4 years ago

Pfizer’s Covid story — and revenue spree — continue with $54B vaccine and pill in spotlight again

4 years ago

FDA hits Miami University in Ohio with a warning letter over falsified data

4 years ago

Two investors team up for CordenPharma buyout following mRNA vaccine success

4 years ago

Where did all the FDA adcomms go? New research digs into steep drop in meetings

4 years ago

Still-in-stealth biotech partners with Sloan Kettering scientists to make personalized cancer therapy more ...

4 years ago

How do you pack 20 years of ADC learnings into one company? Tubulis has $63M more to answer that

4 years ago

After 45 investments in two years, Catalio reels in more funds to back 30 additional companies

4 years ago

As Biogen hunts for a turnaround CEO, execs sketch out a hazy look at an uncertain new future

4 years ago

Supernus' nonstimulant ADHD drug Qelbree gains approval for adult use

4 years ago

MarketingRx roundup: AbbVie launches new migraine TV ad with tennis star; Allergan enlists celeb for vision med Vuity

4 years ago

FDA leaders in JAMA: This fall will kick off the 'new normal' of annual Covid-19 boosters

4 years ago

Genentech-partnered Genesis Therapeutics inks newest AI discovery deal with Eli Lilly

4 years ago

Following student and faculty protests, David Sabatini withdraws from NYU job consideration

4 years ago

Frank Zhang is in the clear after Chinese authorities conclude investigation without charges, company says

4 years ago

Sanofi and Regeneron grow marketing for Dupixent's ‘do list’ with asthma campaign evolution

4 years ago

Two struggling biotechs fall under bear market influence, as Spero sharply reduces staff and Sesen seeks sale

4 years ago

5AM, Avidity, Fidelity lead $100M infusion into next-gen, targeted complement approach

4 years ago

Michel Vounatsos is on his way out as Biogen shutters Aduhelm effort and launches pipeline reorg

4 years ago

Fifth individual charged in conspiracy to steal GlaxoSmithKline trade secrets, faces up to 10-year sentence

4 years ago

GSK beat six other companies to the Sierra deal table and prevailed after initial $46 per share bid

4 years ago

A year after CRL, Acadia is going back to bat for Nuplazid at the FDA

4 years ago

Wait, what? Oracle tech founder Larry Ellison invests into ex-stealth genomics diagnostics biotech

4 years ago

First page Previous page 528 529 530531532 533 534 Next page Last page